Software AG

  • WKN: A2GS40
  • ISIN: DE000A2GS401
  • Land: Germany

Nachricht vom 03.09.2015 | 19:51

Software AG decides on Share Buyback


Software AG  / Key word(s): Share Buyback

03.09.2015 19:51

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Software AG decides on Share Buyback Software AG's executive board (TecDAX, ISIN DE 0003304002 / SOW) today decided, on the basis of the authority granted by the general meeting of May 13, 2015 and with the approval of the supervisory board, to conduct a buyback of own shares in a value of up to EUR 70 million (excluding ancillary costs) during the period until December 31, 2015 at the latest. Based on the Xetra closing rate on September 2, 2015 of EUR 24.02 this equates to a volume of up to approx. 2,914,238 shares. The limit for a share buyback is 10 percent of the share capital as of the date of the resolution less other treasury shares, which the Company has previously purchased or still holds or which are attributable to it under the provisions of §§ 71d and 71e AktG (German Stock Corporation Act), which equals 7,838,144 shares. It is intended that the share buyback will be conducted through a bank and exclusively on the stock exchange. The shares bought back may be used for all purposes permissible under the above mentioned authority and applicable stock corporation law. Darmstadt, September 3, 2015 The Executive Board Software AG, Uhlandstr. 12, 64297 Darmstadt, Germany 03.09.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Software AG Uhlandstraße 12 64297 Darmstadt Germany Phone: +49 (0)6151 92-1900 Fax: +49 (0)6151 92-34 1899 E-mail: Investor.Relations@softwareag.com Internet: www.softwareag.com ISIN: DE0003304002 WKN: 330400 Indices: TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021